Regulation of the Reactive Species Interactome by Prokineticin Antagonist in Cerebral Dementia
The Redox Medicine Society is pleased to welcome Prof. Christel Marquette, from the Laboratoire Biosanté U1292 INSERM-CEA-UGA, Equipe MAB2, France, to the 26th International Conference "Redox Medicine 2024" this June in Paris.
Title: Regulation of the Reactive Species Interactome by Prokineticin Antagonist in Cerebral Dementia
About Prof. Marquette
Christel Marquette is a Research Director at the French Alternative Energies and Atomic Energy Commission (CEA). Her recent research investigates the effects of prokineticins on cerebral cell function and blood-brain barrier permeability, contributing to the understanding of neurovascular interactions and potential therapeutic avenues for neurological disorders.
Redox Medicine 2024 Speaker Line-up.
Redox Medicine Society
Redox Medicine 2024 Conference
June 27-28 - Paris, France
Press Releases | Newsletters Archive | LinkedIn
